BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Aplagon readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Aplagon's drugs run\, from Clinic
 alTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07352800-1263@assetmemo.bio
DTSTAMP:20261121T005822Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:APAC: Phase 2 readout est. (NCT07352800)
DESCRIPTION:APAC\, phase 2\, Atherosclerotic Cardiovascular Disease.\nStudy
 : Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral
  Arterial Occlusive Disease and Chronic Limb-threatening Ischemia\nEstimat
 ed primary completion: 30 June 2027. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/apac#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT07352800
URL:https://assetmemo.bio/drug/apac#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
